PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.79%
Revenue growth at 75-90% of MRVL's 8.33%. Bill Ackman would push for innovation or market expansion to catch up.
7.87%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
20.72%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
12.68%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
24.76%
Net income growth under 50% of MRVL's 2248.67%. Michael Burry would suspect the firm is falling well behind a key competitor.
24.49%
EPS growth under 50% of MRVL's 2316.67%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
24.14%
Diluted EPS growth under 50% of MRVL's 2283.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.22%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.32%
Diluted share reduction more than 1.5x MRVL's 1.13%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
13.33%
Dividend growth above 1.5x MRVL's 0.24%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
47.26%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
47.49%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
47.46%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
40.65%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
16.50%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
120.33%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
63.52%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
18.07%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
128.52%
Below 50% of MRVL's 711.34%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
122.19%
Below 50% of MRVL's 1574.40%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
425.94%
Below 50% of MRVL's 1788.80%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
12.26%
Below 50% of MRVL's 84.15%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
1.64%
Below 50% of MRVL's 30.13%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.74%
Negative 3Y equity/share growth while MRVL is at 64.41%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
681.02%
Dividend/share CAGR of 681.02% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
167.12%
Stable or rising mid-term dividends while MRVL is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
64.37%
3Y dividend/share CAGR above 1.5x MRVL's 0.40%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
1.58%
Our AR growth while MRVL is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-5.65%
Inventory is declining while MRVL stands at 4.76%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
6.28%
Asset growth at 75-90% of MRVL's 8.06%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
10.11%
Under 50% of MRVL's 21.59%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
4.74%
We have some new debt while MRVL reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.52%
R&D dropping or stable vs. MRVL's 4.33%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-2.21%
We cut SG&A while MRVL invests at 2.18%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.